Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
LeMaitre Vascular, Inc.
LeMaitre Vascular makes and sells medical devices used in vascular surgery, along with services that preserve human tissue for use in operations.
LeMaitre Vascular is a medical device company that sells the specialized tools surgeons use to fix blood vessels. Its customers are vascular surgeons and the hospitals where they operate. When a person's arteries or veins are narrowed, blocked, or ballooning dangerously, a surgeon has to open them up, patch them, or reroute the blood — and LeMaitre makes many of the small, precise devices that make those repairs possible.
The product lineup is broad but focused. It includes things like balloon catheters that widen a clogged vessel, patches used to close an artery after surgery, and devices that help tie off or remove problem veins. The company also runs a tissue bank: it recovers, processes, and preserves human veins and other tissue that surgeons can implant when a patient's own vessels aren't usable. Hospitals pay for each device they use and for the preserved tissue, so the money comes from the procedures themselves rather than from one big customer contract. What makes the business interesting is that vascular surgery is a niche. The big medical device giants sell plenty of heart and stent products, but LeMaitre has built a living by focusing narrowly on the open-surgery tools that specialists need. That focus, plus a long history of buying up small rival products and folding them into its sales force, has let it grow steadily. It is headquartered near Boston, and it sells in many countries, not just the United States.
The company is profitable and generates real cash, which it tends to spend on dividends, buying back its own shares, and acquiring smaller device makers or product lines to bolt onto its catalog. The honest view: this is a steady, unglamorous, niche player, not a high-flying growth story. Its risk is that open vascular surgery is a mature field, and newer minimally invasive techniques could slowly shrink the pool of procedures that need its tools. For now, though, LeMaitre owns a small, sturdy corner of the operating room.
Saved answer · last researched 14 Nov 2026